These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma. Chesler L; Schlieve C; Goldenberg DD; Kenney A; Kim G; McMillan A; Matthay KK; Rowitch D; Weiss WA Cancer Res; 2006 Aug; 66(16):8139-46. PubMed ID: 16912192 [TBL] [Abstract][Full Text] [Related]
52. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177 [TBL] [Abstract][Full Text] [Related]
53. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Yi JS; Sias-Garcia O; Nasholm N; Hu X; Iniguez AB; Hall MD; Davis M; Guha R; Moreno-Smith M; Barbieri E; Duong K; Koach J; Qi J; Bradner JE; Stegmaier K; Weiss WA; Gustafson WC Neoplasia; 2021 Jun; 23(6):624-633. PubMed ID: 34107377 [TBL] [Abstract][Full Text] [Related]
54. p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Tweddle DA; Malcolm AJ; Cole M; Pearson AD; Lunec J Am J Pathol; 2001 Jun; 158(6):2067-77. PubMed ID: 11395384 [TBL] [Abstract][Full Text] [Related]
55. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. Faisal A; Vaughan L; Bavetsias V; Sun C; Atrash B; Avery S; Jamin Y; Robinson SP; Workman P; Blagg J; Raynaud FI; Eccles SA; Chesler L; Linardopoulos S Mol Cancer Ther; 2011 Nov; 10(11):2115-23. PubMed ID: 21885865 [TBL] [Abstract][Full Text] [Related]
56. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line. Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372 [TBL] [Abstract][Full Text] [Related]
57. NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells. Shoji W; Suenaga Y; Kaneko Y; Islam SM; Alagu J; Yokoi S; Nio M; Nakagawara A Biochem Biophys Res Commun; 2015 Jun; 461(3):501-6. PubMed ID: 25896758 [TBL] [Abstract][Full Text] [Related]
58. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Liontas A; Yeger H Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054 [TBL] [Abstract][Full Text] [Related]
59. Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells. Chayka O; D'Acunto CW; Middleton O; Arab M; Sala A J Biol Chem; 2015 Jan; 290(4):2198-212. PubMed ID: 25477524 [TBL] [Abstract][Full Text] [Related]
60. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Chen Y; Stallings RL Cancer Res; 2007 Feb; 67(3):976-83. PubMed ID: 17283129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]